XML 16 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Operations - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Revenue:        
Net product sales $ 94,503 $ 80,731 $ 180,773 $ 159,446
Cost of goods sold 9,114 8,197 16,056 15,779
Gross profit 85,389 72,534 164,717 143,667
Operating expenses:        
Research and development 35,149 78,319 76,648 159,836
Selling, general, and administrative 65,423 53,379 139,380 111,495
Changes in fair value of contingent consideration payable 337 115 588 (1,073)
Loss on impairment of assets 1,134 0 1,134 6,616
Depreciation and amortization 2,206 1,334 3,463 2,745
Total operating expenses 104,249 133,147 221,213 279,619
Loss from operations (18,860) (60,613) (56,496) (135,952)
Other (expense) income:        
Interest income 1,737 356 3,936 489
Interest expense (12,492) (8,257) (24,336) (16,404)
Other (expense) income (10,902) 7,268 (16,840) 9,170
Loss before income tax (40,517) (61,246) (93,736) (142,697)
Income tax expense (2,715) (911) (2,428) (4,720)
Net loss attributable to common stockholders $ (43,232) $ (62,157) $ (96,164) $ (147,417)
Net loss attributable to common stockholders per common share - basic (in dollars per share) $ (0.15) $ (0.21) $ (0.33) $ (0.51)
Net loss attributable to common stockholders per common share — diluted (in dollars per share) $ (0.15) $ (0.21) $ (0.33) $ (0.51)
Weighted average common shares outstanding - basic (in shares) 292,797,002 291,970,562 292,071,201 288,646,587
Weighted average common shares outstanding - diluted (in shares) 292,797,002 291,970,562 292,071,201 288,646,587